Clarify Stock

Delivers actionable insights from complex medical data to support better care and operational decisions.

Buy

Buy Clarify shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Clarify shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Clarify Health is a healthcare analytics company that provides advanced data-driven insights to improve patient care and operational efficiency. Clarify Health focuses on leveraging extensive healthcare data to support decision-making for providers, payers, and life sciences organizations.

Sector

Healthcare & Life Sciences

Founded

2015

Headquarters

San Francisco, CA

Clarify Funding

Clarify Funding History

Sign up to gain insights into Clarify funding history, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series D Apr 05, 2022 19M
XXXXX
XXXXX
Series D Apr 05, 2022 166M
XXXXX
XXXXX
Series C-2 Feb 26, 2021 76M
XXXXX
XXXXX
Series C Feb 26, 2021 24M
XXXXX
XXXXX
Series C Apr 03, 2020 17M
XXXXX
XXXXX
Series B Aug 21, 2019 45M
XXXXX
XXXXX
Series B Sep 05, 2018 37M
XXXXX
XXXXX
Series A Oct 03, 2016 2M
XXXXX
XXXXX
Series A May 31, 2016 3M
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Clarify shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Clarify shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Clarify Management Team

Clarify people and management

  • Founder, CEO, Board Member
    Todd Gottula
  • Co-Founder
    Terry Boch
  • CFO
    Christine Gu
  • CMO
    Sabrina Poon
  • COO
    Eliza Adams
  • CRO
    Walker Hale
  • CTO
    Justin Warner
  • Board Member
    David Grayce
  • Board Member
    Johnny Kim
  • Board Member
    Will Reed
  • Chief Customer Officer
    John Barzydlo
  • Chief Information Security Officer
    Fred Bret-Mounet

Investors

Major Clarify investors

  • Aspenwood Ventures

  • BlackRock

  • Concord Health Partners

  • HWVP

  • Insight Partners

  • KKR

  • Kohlberg Ventures LLC

  • Memorial Hermann Health System

  • Rivas Capital

  • Rivas Capital LLC

  • Sigmas Group

  • Softbank Vision Fund 2

  • Spark Capital

Clarify Valuations & Financials

Gain Insights Into Clarify Stock Valuation & Share Prices

View real-time NPM data on Clarify stock including daily Clarify stock price estimates, valuation history, and historical share price information. Access Clarify financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Clarify pricing across six independent market signals. Looking for private company due diligence data sources on Clarify? Get in touch to learn more.

Similar Companies

Explore companies

like Clarify

  • PicnicHealth

    Healthcare & Life Sciences

    Transforms fragmented medical histories into accessible patient timelines and research-grade data.

  • Actio Biosciences

    Healthcare & Life Sciences

    Advances therapies which target genetic drivers in rare and common diseases via a precision‑medicine platform.

  • Collectly

    Healthcare & Life Sciences

    A comprehensive platform that enhances patient financial experiences by streamlining billing processes and accelerating cash flow.

  • Ayble Health

    Healthcare & Life Sciences

    Provides a digital program combining nutrition, behavioral therapy, and coaching for people with chronic gut conditions.

  • Synthpop

    Healthcare & Life Sciences

    A healthcare AI company that automates administrative workflows to reduce operational bottlenecks for providers.

  • Angitia Biopharmaceuticals

    Healthcare & Life Sciences

    Develops innovative biologic therapies for serious musculoskeletal diseases like osteoporosis, osteogenesis imperfecta, and spinal fusion.

  • Earli

    Healthcare & Life Sciences

    Forces cancer cells to produce a synthetic biomarker, enabling precise PET scan detection through gene therapy-based Synthetic Biopsy.

  • SCG Cell Therapy

    Healthcare & Life Sciences

    Develops immunotherapy treatments for chronic infections and cancers using T-cell receptor technology to enhance immune system response.

  • Differentiated Therapeutics

    Healthcare & Life Sciences

    Develops novel protein degrader therapeutics using an AI-driven platform to target and eliminate disease-causing proteins.

FAQ

Questions?

We have answers

Buy Clarify Stock

Clarify stock does not trade on public stock exchanges. Clarify stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Clarify stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Clarify Stock

Clarify Stock does not trade on public stock exchanges. In order to sell Clarify shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Clarify Stock Price

Clarify does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Clarify share price and other valuable private market data.

Read more about secondary market private company stock prices:

Clarify Stock Ticker Symbol

There is no ticker symbol for Clarify stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Clarify Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Clarify stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Clarify Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Clarify stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Clarify Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Clarify IPO

Clarify is a private company and has not had an IPO. There is currently no Clarify IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Clarify IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.